☰

Sarah T. Pruett, Ph.D. - Publications

Affiliations: 
Emory University, Atlanta, GA 
Area:
Medicinal, Bioorganic, Synthetic Organic, Computational
Tree Info Similar researchers PubMed Report error

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Miller EJ, Mays SG, Baillie MT, Howard RB, Culver DG, Saindane M, Pruett ST, Holt JJ, Menaldino DS, Evers TJ, Reddy GP, Arrendale RF, Natchus MG, Petros JA, Liotta DC. Discovery of a Fluorinated Enigmol Analog with Enhanced in Vivo Pharmacokinetic and Anti-Tumor Properties. Acs Medicinal Chemistry Letters. 7: 537-42. PMID 27190606 DOI: 10.1021/Acsmedchemlett.6B00113  0.556
2014 Hu H, Mao S, Bugrysheva JV, Pruett S, Liotta DC, Scott JR, Snyder JP. Group A streptococcus inhibitors by high-throughput virtual screening. European Journal of Medicinal Chemistry. 82: 120-6. PMID 24880231 DOI: 10.1016/J.Ejmech.2014.05.006  0.527
2013 Mays SG, Baillie MT, Miller EJ, Bushnev AS, Pruett ST, Culver DG, Evers TJ, Gao J, Reddy GP, Natchus MG, Arrendale RF, Howard RB, Liotta DC, Petros JA. 330 FLUORINATION OF ENIGMOL IMPROVES TISSUE UPTAKE AND AFFECTS IN VIVO PROSTATE CANCER EFFICACY Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1715  0.558
2011 Symolon H, Bushnev A, Peng Q, Ramaraju H, Mays SG, Allegood JC, Pruett ST, Sullards MC, Dillehay DL, Liotta DC, Merrill AH. Enigmol: A novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer Molecular Cancer Therapeutics. 10: 648-657. PMID 21398423 DOI: 10.1158/1535-7163.Mct-10-0754  0.54
2009 Zitomer NC, Mitchell T, Voss KA, Bondy GS, Pruett ST, Garnier-Amblard EC, Liebeskind LS, Park H, Wang E, Sulllards MC, Merrill AH, Riley RT. Ceramide synthase inhibition by fumonisin B1 causes accumulation of 1-deoxysphinganine. A novel category of bioactive 1-deoxysphingoid bases and 1-deoxydihydroceramides biosynthesized by mammalian cell lines and animals Journal of Biological Chemistry. 284: 4786-4795. PMID 19095642 DOI: 10.1074/Jbc.M808798200  0.318
2008 Pruett ST, Bushnev A, Hagedorn K, Adiga M, Haynes CA, Sullards MC, Liotta DC, Merrill AH. Biodiversity of sphingoid bases ("sphingosines") and related amino alcohols Journal of Lipid Research. 49: 1621-1639. PMID 18499644 DOI: 10.1194/Jlr.R800012-Jlr200  0.421
2007 Morales PR, Dillehay DL, Moody SJ, Pallas DC, Pruett S, Allgood JC, Symolon H, Merrill AH. Safingol toxicology after oral administration to TRAMP mice: demonstration of safingol uptake and metabolism by N-acylation and N-methylation. Drug and Chemical Toxicology. 30: 197-216. PMID 17613006 DOI: 10.1080/01480540701375018  0.325
Show low-probability matches.